A 3-year postmarketing study on the safety and effectiveness of once-monthly risedronate in Japanese patients with osteoporosis

OBJECTIVES: This postmarketing study aims to evaluate the safety and effectiveness of oral administration of risedronate at 75 mg once monthly for 36 months in patients with osteoporosis in Japan. METHODS: Participants were ambulatory outpatients with osteoporosis who were ≥ 50 years old and had pre...

Descripción completa

Detalles Bibliográficos
Autores principales: Soen, Satoshi, Arai, Yuki, Matsuda, Saori, Emori, Kento, Ikezaki, Toshimi, Osawa, Mitsuharu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Osteoporosis 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7783076/
https://www.ncbi.nlm.nih.gov/pubmed/33426308
http://dx.doi.org/10.1016/j.afos.2020.11.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7783076/
https://www.ncbi.nlm.nih.gov/pubmed/33426308
http://dx.doi.org/10.1016/j.afos.2020.11.002

Ejemplares similares